Welcome to our dedicated page for Doximity SEC filings (Ticker: DOCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Doximity’s filings don’t read like a traditional tech company; every page weaves HIPAA obligations, clinician engagement metrics, and life-science ad revenue into one dense narrative. If you need the Doximity annual report 10-K simplified or want to see how tele-health adoption shifts quarter-to-quarter inside a Doximity quarterly earnings report 10-Q filing, you’re in the right place.
Stock Titan applies AI models built for regulatory language, understanding Doximity SEC documents with AI so you don’t have to. We tag risk factors, pull out user-growth charts, and alert you to Doximity insider trading Form 4 transactions within minutes of submission. Whether it’s a sudden product-launch 8-K or the annual Doximity proxy statement executive compensation, our platform delivers context alongside the raw text.
Use cases our members rely on every day:
- Instant push notifications for Doximity Form 4 insider transactions real-time and other executive stock moves.
- Side-by-side redlines that make a Doximity earnings report filing analysis a two-minute task, not an afternoon.
- One-click highlights that turn “Risk Factors” into an at-a-glance checklist, making Doximity 8-K material events explained in plain English.
From Doximity executive stock transactions Form 4 to the next Doximity SEC filings explained simply, every document flows into our real-time feed, fully searchable and linked to prior periods. Spend less time hunting through EDGAR and more time acting on clear, AI-powered insights.
Benjamin Regina M., a director of Doximity, Inc. (DOCS), reported transactions dated 08/08/2025. The Form 4 shows the conversion of 5,000 shares of Class B Common Stock into Class A Common Stock and the sale of 5,000 shares of Class A Common Stock at $63 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted February 26, 2025.
Following the reported transactions the form lists the Reporting Person's beneficial ownership as 16,618 shares of Class A Common Stock. The filing also discloses derivative/option positions, with one line showing 361,138 derivative-equivalent shares beneficially owned after the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/11/2025.
Form 144 filed for proposed sale of common stock. The notice reports a proposed sale of 5,000 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $315,000 and states total shares outstanding of 187,299,459. The securities are shown as acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash.
The filing also discloses prior sales by the same account in the past three months: 5,000 shares sold on 07/11/2025 for $300,200 and 10,000 shares sold on 06/25/2025 for $600,000. The signer attests they have no undisclosed material information as of the notice.
FAQ
What is the current stock price of Doximity (DOCS)?
What is the market cap of Doximity (DOCS)?
